Pointe Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Pointe Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,872	Closed	-$199K	–	184
2023 Q1	$199K	Buy	+2,872	New	+$203K	0.14%	143
2018 Q1	–	Sell	-4,278	Closed	-$262K	–	148
2017 Q4	$262K	Hold	4,278	–	–	0.21%	130
2017 Q3	$273K	Sell	4,278 -8,000	-65%	-$467K	0.2%	129
2017 Q2	$684K	Buy	+12,278	New	+$668K	0.49%	60

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pointe Capital Management's BMY Position: Q2 2023 in Review

Pointe Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 2,872 shares — an estimated $199K sold.

Pointe Capital Management first reported a position in BMY in Q2 2017 and held it in 4 quarters. The position peaked at $684K in Q2 2017. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Pointe Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Pointe Capital Management sold 2,872 Bristol-Myers Squibb shares in Q2 2023, an estimated $199K.
Pointe Capital Management first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 4 quarters.
Pointe Capital Management's Bristol-Myers Squibb position peaked at $684K in Q2 2017.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.